C. Ryan Miller

MD, PhD, Pathology & Lab Medicine, UNC-Chapel Hill, Clinical Research, Neuro-oncology Program

C. Ryan Miller

Pathology & Lab Medicine
UNC-Chapel Hill
Clinical Research
Neuro-oncology Program

6109B Neurosciences Research Building

CRM Research Lab Website

Area of interest

Gliomas are a diverse group of primary brain tumors currently diagnosed via the microscope and treated empirically with radiation and chemotherapy.  Even with aggressive treatment, prognosis remains only ~15 months for the most malignant of these tumors, glioblastoma. Although diagnostic criteria have recently been updated to include molecular tumor features, therapy remains empirical.  Novel treatment approaches that are based on the molecular alterations responsible for tumorigenesis are urgently needed.

The main goal of our work is to establish a direct link between preclinical drug development in glioma models and the rational design of molecular diagnostics-driven human clinical trials.  Our laboratory uses sophisticated preclinical model systems (genetically-engineered mice and patient-derived xenografts), comprehensive genomic and proteomic molecular analyses, and developmental neurobiology techniques to address the following issues:

  1. Dissect the genetic mechanisms of glioma tumorigenesis in order to identify molecular markers with prognostic and predictive utility
  2. Define the role of cellular origin on disease pathogenesis
  3. Identify novel therapeutic strategies that are effective in molecularly-defined glioma subtypes

Awards and Honors

2015 Neuro-oncology Top Reviewer Award, Society for Neuro-oncology

2015 Best Oral Poster Presentation Award, Society for Neuro-oncology 20th Annual Scientific Meeting Tumor Biology 1 Session

2012 Highly Rated Poster Award, American Association for Cancer Research 103rd Annual Meeting

2012 Society for Neuro-oncology Adult Basic Science Award

2012 American Association of Neuropathologists Lucien J. Rubenstein Award

2012 UNC Weatherspoon Family Brain Tumor Research Award

2009 Damon Runyon-Genentech Clinical Scholar, Damon Runyon Cancer Research Foundation

2007 American Association of Neuropathologists Moore Award

2007 American Association of Neuropathologists Merit Award

2006 American Society of Clinical Oncology Merit Award

2005 American Association of Neuropathologists Merit Award 

2000 American Brain Tumor Association Lucien J. Rubenstein Award

Link to Publications on Reach NC site

Find Publications on Pubmed